These Three Stocks Are Where Marijuana and Dividends Intersect

0 | By Michael A. Robinson

I love when you folks send me questions.

I love it even more when your questions lead me to an investing idea I can then share with you.

A lot of you ask me about tech dividend stocks. You’re looking for the growth of tech stocks – along with the income dividend payers provide.

That makes a lot of sense to me.

Even more of you ask me about pot stocks – and how to invest in them.

And just recently one of you asked me about dividend-paying legal cannabis stocks – about whether they even exist.

Well, they do.

After all, every Venn diagram has its union.

Of course, most cannabis growers and dispensaries haven’t been established long enough to make a profit, let alone pay a portion of their profits to shareholders in the form of dividends.

However, there are marijuana “pick-and-shovel” plays that offer hefty dividends.

Here are three of my favorite marijuana dividend stock plays now, plus one that is set to soar in the coming weeks…

This Pick Is Just What the Software Engineer Ordered

0 | By Michael A. Robinson

I’m not average.

For one, I’m a bit taller than the average guy. My hair went silver earlier than I expected. And I’m fortunate that it’s easier for me to keep trim than a lot of people I know.

On the downside, I’ve got various allergies and genetic maladies that most folks don’t.

My environment isn’t average either. Here in Silicon Valley and the San Francisco Bay Area, I spend my days in some of the most polluted cities in the United States. Of course, in other ways, this region rates much higher than most of America.

Then there are my habits. For example, I eat well, but don’t get to the gym enough.

I bet you’re the same way – but different.

No one is average.

And that’s why it often seems like maintaining a healthy diet, getting plenty of exercise, and regular checkups just aren’t enough to keep us healthy. If it were, no one would gain too much weight, go bald at 30, or get cancer.

By our very nature, each of us is so unique that this one-size-fits-all approach just isn’t enough.

That’s what opened the door for an emerging field known as precision medicine. The idea here is to set up disease prevention and treatment measures for each and every individual, accounting for your genes, environment, and lifestyle… for my genes, environment, and lifestyle.

Think of it as a partnership – a “convergence” – among traditional medicine, molecular biology, data analysis, and cloud computing.

Doctors and other medical diagnosticians collect our info, and then feed it to the cloud. There software and data scientists can crunch through all that data – and then use what they turn up to prescribe precise disease treatments and preventative measures for each individual.

Mordor Intelligence has run the numbers – and says precision medicine will be worth $59.2 billion by 2021

And I’ve spotted a hidden way to play this hot new field with a stock with which you’ll soon be quadrupling the market’s return